These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
278 related items for PubMed ID: 18940019
21. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, Tsai FJ. J Rheumatol; 2008 Jul; 35(7):1408-13. PubMed ID: 18484687 [Abstract] [Full Text] [Related]
22. Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis. Pawlik A, Kurzawski M, Drozdzik M, Dziedziejko V, Safranow K, Herczynska M. Scand J Rheumatol; 2009 Jul; 38(3):159-65. PubMed ID: 19229765 [Abstract] [Full Text] [Related]
23. Interleukin-18-promoter polymorphisms are not relevant in rheumatoid arthritis. Rueda B, González-Gay MA, Mataran L, López-Nevot MA, Martín J. Tissue Antigens; 2005 Jun; 65(6):544-8. PubMed ID: 15896202 [Abstract] [Full Text] [Related]
24. DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder. Ma X, Xu H, Zheng T, Li HZ, Shi TP, Wang BJ, Ju ZH, Wang C, Zhang GX, Zhang X. BJU Int; 2008 Aug 05; 102(5):633-6. PubMed ID: 18384629 [Abstract] [Full Text] [Related]
25. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Csejtei A, Tibold A, Koltai K, Varga Z, Szanyi I, Gobel G, Prantner I, Steffler D, Feher G, De Blasio A, Ember I, Kiss I. Anticancer Res; 2009 Oct 05; 29(10):4169-73. PubMed ID: 19846968 [Abstract] [Full Text] [Related]
26. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Chaudhary AK, Pandya S, Mehrotra R, Singh M, Singh M. Biomarkers; 2011 Nov 05; 16(7):577-86. PubMed ID: 21958210 [Abstract] [Full Text] [Related]
27. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. Haghshenas MR, Hosseini SV, Mahmoudi M, Saberi-Firozi M, Farjadian S, Ghaderi A. J Gastroenterol Hepatol; 2009 Jun 05; 24(6):1119-22. PubMed ID: 19638090 [Abstract] [Full Text] [Related]
28. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Novota P, Kolostova K, Pinterova D, Novak J, Treslova L, Andel M, Cerna M. Immunol Lett; 2005 Jan 31; 96(2):247-51. PubMed ID: 15585330 [Abstract] [Full Text] [Related]
29. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Zhang Z, Wang LE, Sturgis EM, El-Naggar AK, Hong WK, Amos CI, Spitz MR, Wei Q. Clin Cancer Res; 2006 Sep 15; 12(18):5596-602. PubMed ID: 17000697 [Abstract] [Full Text] [Related]
30. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Tu HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. J Oral Pathol Med; 2007 Aug 15; 36(7):409-14. PubMed ID: 17617834 [Abstract] [Full Text] [Related]
31. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Baran W, Szepietowski JC, Mazur G, Baran E. Acta Derm Venereol; 2008 Aug 15; 88(2):113-6. PubMed ID: 18311435 [Abstract] [Full Text] [Related]
33. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Amiri HM, Rashidi A, Solgi G, Parivar K, Nikbin B, Amirzargar A. Eur J Intern Med; 2009 Jul 15; 20(4):424-8. PubMed ID: 19524188 [Abstract] [Full Text] [Related]
34. Haplotype analysis of the interleukin-18 gene in Czech patients with allergic disorders. Izakovicova Holla L, Hrdlicková B, Schüller M, Buckova D, Kindlova D, Izakovic V, Vasku A. Hum Immunol; 2010 Jun 15; 71(6):592-7. PubMed ID: 20304021 [Abstract] [Full Text] [Related]
35. Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Michiels S, Danoy P, Dessen P, Bera A, Boulet T, Bouchardy C, Lathrop M, Sarasin A, Benhamou S. Carcinogenesis; 2007 Aug 15; 28(8):1731-9. PubMed ID: 17494052 [Abstract] [Full Text] [Related]
36. Interleukin-24, RANTES and CCR5 gene polymorphisms are not associated with chronic adult periodontitis. Savarrio L, Donati M, Carr C, Kinane DF, Berglundh T. J Periodontal Res; 2007 Apr 15; 42(2):152-8. PubMed ID: 17305874 [Abstract] [Full Text] [Related]
38. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population. Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M. Biomarkers; 2010 Dec 15; 15(8):684-92. PubMed ID: 20860530 [Abstract] [Full Text] [Related]
39. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression an overall survival in patients with head and neck squamous cell carcinoma. Lehnerdt GF, Franz P, Bankfalvi A, Grehl S, Jahnke K, Lang S, Schmid KW, Siffert W, Frey UH. Cancer Epidemiol Biomarkers Prev; 2008 Nov 15; 17(11):3203-7. PubMed ID: 18990763 [Abstract] [Full Text] [Related]
40. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Yu JT, Tan L, Song JH, Sun YP, Chen W, Miao D, Tian Y. Brain Res; 2009 Feb 09; 1253():169-75. PubMed ID: 19073159 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]